HK Stock Market Move | SHANDONG XINHUA (00719) surged over 8% in morning trading; levocarnitine oral solution and others obtained drug registration certificates.

SHANDONG XINHUA (00719) rose over 8% in morning trading. As of press time, it was up 8.74% at HK$6.035, with a turnover of HK$19.3452 million. On the news front, Shandong Xinhua Pharmaceutical announced that the company recently received the "Drug Registration Certificate" for Levocarnitine Oral Solution and Sodium Magnesium Potassium Sulfate Oral Concentrated Solution approved and issued by the National Medical Products Administration, and its wholly-owned subsidiary Shandong Zibo Xinda Pharmaceutical Co., Ltd. received the "Drug Registration Certificate" for Donepezil Hydrochloride Orally Disintegrating Tablets approved and issued by the National Medical Products Administration. Levocarnitine Oral Solution is used for the treatment of primary systemic carnitine deficiency. Sodium Magnesium Potassium Sulfate Oral Concentrated Solution is indicated for adults for bowel cleansing before any procedure requiring a clean bowel. Donepezil Hydrochloride Orally Disintegrating Tablets are used for the treatment of mild, moderate, or severe symptoms of Alzheimer's disease.